Poor
Not Aligned
Patient Risk:
Low
Summary
Only brand-name and naming-format claims were evaluated. The provided label excerpts do not include brand names (Ultram/Ultram ER/Ryzolt/Conzip) or prescription wording formats (e.g., “tramadol hydrochloride”); therefore these claims are unsupported based on the supplied prescribing information.
Category Scores
Accurate Statements
Unsupported Statements
Tramadol is also known by the brand name Ultram.
The supplied label excerpts (Sections 1, 2, 4, 5, 6, 7, 8, 11, 12, 14) do not mention any brand name equivalences such as “Ultram”.
Tramadol is also known by the brand name Ultram ER (extended-release).
The supplied label excerpts do not mention “Ultram ER” or any brand-name mapping for extended-release tramadol.
Tramadol is also known by the brand name Ryzolt (extended-release).
The supplied label excerpts do not mention “Ryzolt”.
Tramadol is also known by the brand name Conzip (extended-release).
The supplied label excerpts do not mention “Conzip”.
Tramadol may appear as “tramadol hydrochloride” on prescriptions.
The supplied label excerpts do not describe how tramadol appears on prescriptions (e.g., exact prescriber-facing naming/formatting).
Contradictions
Important Omissions
Label-supported verification of the brand names (Ultram, Ultram ER, Ryzolt, Conzip) and the specific prescription naming phrasing.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The evaluated claims are labeling/name associations without dosage or safety guidance. Based on the provided excerpts, they are unsupported rather than contradicted; unsupported nomenclature claims carry limited direct clinical risk compared with dosing or contraindication errors.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Aligned
Primary Issue
Brand-name and prescription-naming claims are not supported by the provided FDA label excerpts.
Suggested Improvement
Remove or revise brand-name equivalence and prescription-format claims unless supported by text explicitly present in the provided prescribing information (e.g., a label section listing brand name(s) or specific prescriber naming conventions).